(Q30397875)

21 June 2017

1 reference

title

Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention (English)

1 reference

21 June 2017

1 reference

Richard Kones

1

1 reference

21 June 2017

publication date

23 December 2010

1 reference

Therapeutic advances in cardiovascular disease

21 June 2017

published in

1 reference

21 June 2017

volume

5

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

61-81

1 reference

Improving health outcomes with better patient understanding and education

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Targeting residual risk: the rationale for the use of non-HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Diet first, then medication for hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Medication adherence in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Screening for cardiovascular risk in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Framingham risk score and prediction of coronary heart disease death in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Can the polypill save the world from heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Primary prevention of stroke by healthy lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Does preventive care save money? Health economics and the presidential candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Characteristics of contemporary patients with hypertension and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Medical management of patients before the incidence of a cardiovascular event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Relation between modifiable lifestyle factors and lifetime risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Deaths preventable in the U.S. by improvements in use of clinical preventive services

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Diet and lifestyle risk factors associated with incident hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Prime time for a polypill after myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Children are key to CVD prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

A polypill for secondary prevention: time to move from intellectual debate to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Aldosterone production and insulin resistance in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Short communication: Dating components of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Improving lipid goal attainment: is it enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Dietary advice for patients undergoing coronary artery bypass surgery: falling on deaf ears?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

An integrative view of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Why we don't spend enough on public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Primary prevention of cardiovascular disease: time to get more or less personal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Medication adherence: its importance in cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Impact of medication therapy discontinuation on mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Adherence to 2005 Dietary Guidelines for Americans is associated with a reduced progression of coronary artery atherosclerosis in women with established coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The impact of prevention on reducing the burden of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Patterns of recommended dietary behaviors predict subsequent risk of mortality in a large cohort of men and women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Attainment of low-density lipoprotein cholesterol goals in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Body mass index and vigorous physical activity and the risk of heart failure among men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

A 2020 vision for healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Influence of individual and combined health behaviors on total and cause-specific mortality in men and women: the United Kingdom health and lifestyle survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Physical activity and weight gain prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The forgotten majority: unfinished business in cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Cardiovascular risk prediction: basic concepts, current status, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Dietary quality 1 year after diagnosis of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Priorities among effective clinical preventive services: results of a systematic review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Cardiovascular risk estimation: important but may be inaccurate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Actual causes of death in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The quality of health care delivered to adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Hypertension 2008--awareness, understanding, and treatment of previously diagnosed hypertension in baby boomers and seniors: a survey conducted by Harris interactive on behalf of the Preventive Cardiovascular Nurses Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Body mass index and blood pressure: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

High-density lipoprotein and coronary heart disease: current and future therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

ACCORD and Risk-Factor Control in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

High body mass index for age among US children and adolescents, 2003-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Trends in the prevalence of childhood overweight and obesity in Australia between 1985 and 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Avoiding revascularization with lifestyle changes: The Multicenter Lifestyle Demonstration Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Intensive lifestyle changes and health reform

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Intensive lifestyle changes for reversal of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Hierarchical analysis of cardiovascular risk factors in relation to the development of acute coronary syndromes, in different parts of Greece: the CARDIO2000 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The rewards of good behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Recent dynamics suggest selected countries catching up to US obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Healthy lifestyle characteristics among adults in the United States, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Lipid-lowering therapy: strategies for improving compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Is a statin as part of a polypill the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Cost effectiveness of community-based physical activity interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Preventing chronic disease: an important investment, but don't count on cost savings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The Predictive Value of Different Measures of Obesity for Incident Cardiovascular Events and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Dietary intervention to reverse carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The genetic and environmental influences on childhood obesity: a systematic review of twin and adoption studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Secular trends in dietary patterns and obesity-related risk factors in Korean adolescents aged 10-19 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Childhood obesity and overweight prevalence trends in England: evidence for growing socioeconomic disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Primary prevention of coronary heart disease in women through diet and lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

The concept of prevention: a good idea gone astray?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Strength training versus aerobic interval training to modify risk factors of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Forecasting the effects of obesity and smoking on U.S. life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effect of valsartan on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Assessment of claims of improved prediction beyond the Framingham risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Relative importance of borderline and elevated levels of coronary heart disease risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Television, computer use and body mass index in Australian primary school children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

A closer look at the economic argument for disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Impact of obesity on cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

National Cholesterol Education Program risk assessment and potential for risk misclassification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944710391350

Hypertension and Periodontitis: An Upcoming Joint Report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP)

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Screening for diabetes: can we afford not to screen?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Physical Activity and Public Health in Older Adults

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Adherence to the medical regime in patients with heart failure

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

After cardiac surgery, how does nutrition fit in with risk factors?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Risk estimation in 2009

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Improved hypertension control: cause for some celebration

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Placing the cardiovascular risk of childhood obesity in perspective

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Has the risk for coronary heart disease changed among U.S. adults?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Can disease prevention save health reform?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Obesity indicators and cardiometabolic status in 4-y-old children

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Thinking outside the pillbox--medication adherence as a priority for health care reform

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Secondary cardiovascular risk prevention--we can do better

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Control rates of hypertension in North America

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Challenges to improve coronary heart disease risk assessment

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Effectiveness of three models for comprehensive cardiovascular disease risk reduction

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Poor hypertension control: let's stop blaming the patients

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Strategy of prevention: lessons from cardiovascular disease.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Epicardial fat tissue: relationship with cardiorespiratory fitness in men

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1177/1753944710391350

Identifiers

DOI

10.1177/1753944710391350

1 reference

21 June 2017

1 reference